ClinVar Miner

Submissions for variant NM_000249.4(MLH1):c.1938_1945dup (p.Pro649fs)

dbSNP: rs1064794331
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000478853 SCV000568870 likely pathogenic not provided 2015-11-18 criteria provided, single submitter clinical testing This duplication of 8 nucleotides in MLH1 is denoted c.1938_1945dupTGTGCCCC at the cDNA level and p.Pro649LeufsX15(P649LfsX15) at the protein level. The normal sequence, with the bases that are duplicated in braces, is ACTA[TGTGCCCC]CTTT. The duplication causes a frameshift, which changes a Proline to a Leucine at codon 649, and creates a premature stop codon at position 15 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature, it is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. Based on the currently available information, we consider this duplication to be a likely pathogenic variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV000823748 SCV000964618 pathogenic Hereditary nonpolyposis colorectal neoplasms 2021-12-17 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 420181). This variant has not been reported in the literature in individuals affected with MLH1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro649Leufs*15) in the MLH1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MLH1 are known to be pathogenic (PMID: 15713769, 24362816).
Myriad Genetics, Inc. RCV003449205 SCV004189874 pathogenic Colorectal cancer, hereditary nonpolyposis, type 2 2023-07-24 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.